GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BriaCell Therapeutics Corp (STU:8BT) » Definitions » FCF Yield %

BriaCell Therapeutics (STU:8BT) FCF Yield % : -89.55 (As of Apr. 27, 2024)


View and export this data going back to 2016. Start your Free Trial

What is BriaCell Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, BriaCell Therapeutics's Trailing 12-Month Free Cash Flow is €-28.73 Mil, and Market Cap is €31.96 Mil. Therefore, BriaCell Therapeutics's FCF Yield % for today is -89.55%.

The historical rank and industry rank for BriaCell Therapeutics's FCF Yield % or its related term are showing as below:

STU:8BT' s FCF Yield % Range Over the Past 10 Years
Min: -91.84   Med: 0   Max: 0
Current: -89.55


STU:8BT's FCF Yield % is ranked worse than
82.71% of 1550 companies
in the Biotechnology industry
Industry Median: -15.535 vs STU:8BT: -89.55

BriaCell Therapeutics's FCF Margin % for the quarter that ended in Jan. 2024 was 0.00%.


BriaCell Therapeutics FCF Yield % Historical Data

The historical data trend for BriaCell Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BriaCell Therapeutics FCF Yield % Chart

BriaCell Therapeutics Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.68 -26.75 -9.42 -12.74 -23.77

BriaCell Therapeutics Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.17 -19.90 -43.73 -51.50 -43.83

Competitive Comparison of BriaCell Therapeutics's FCF Yield %

For the Biotechnology subindustry, BriaCell Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BriaCell Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BriaCell Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where BriaCell Therapeutics's FCF Yield % falls into.



BriaCell Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

BriaCell Therapeutics's FCF Yield % for the fiscal year that ended in Jul. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-21.465 / 90.296605
=-23.77%

BriaCell Therapeutics's annualized FCF Yield % for the quarter that ended in Jan. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-6.794 * 4 / 62.008996
=-43.83%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BriaCell Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


BriaCell Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of BriaCell Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


BriaCell Therapeutics (STU:8BT) Business Description

Traded in Other Exchanges
Address
235 - 15th Street, Suite 300, West Vancouver, 3rd Floor, Bellevue Centre, Vancouver, BC, CAN, V7T 2X1
BriaCell Therapeutics Corp is an immuno-oncology-focused biotechnology company. The group develops targeted and safe approaches for the management of cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT in metastatic breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for the treatment of advance-stage breast cancer by matching the patient's HLA type.

BriaCell Therapeutics (STU:8BT) Headlines

No Headlines